Enhanced atherogenesis and altered high density lipoprotein in patients with Crohn's disease

• Main Authors: Sander I. van Leuven, Rachel Hezemans, Johannes H. Levels, Susan Snoek, Pieter C. Stokkers, G. Kees Hovingh, John J.P. Kastelein, Erik S. Stroes, Eric de Groot, Daan W. Hommes
• Format: Article
• Language: English
• Published: Elsevier 2007-12-01
• Series: Journal of Lipid Research
• Subjects: atherosclerosis; inflammation; endothelium
• Online Access: http://www.sciencedirect.com/science/article/pii/S0022227520429153

A chronic inflammatory state is a risk factor for accelerated atherogenesis. The aim of our study was to explore whether Crohn's disease (CD), characterized by recurrent inflammatory episodes, is also associated with accelerated atherogenesis. In 60 CD patients and 122 matched controls, carotid intima media thickness (IMT), a validated marker for the burden and progression of atherosclerosis, was assessed ultrasonographically. Additional subgroup analyses, including plasma levels of acute phase reactants and HDL protein profiling, were performed in 11 consecutive patients with CD in remission, 10 patients with active CD, and 15 healthy controls. Carotid IMT in patients with CD was increased compared with healthy volunteers: 0.71 (0.17) versus 0.59 (0.14) mm (P < 0.0001), respectively. In the subgroup analysis, HDL levels in controls and patients in remission were identical [(1.45 (0.48) and 1.40 (0.46) mmol/l; P = 0.797], whereas HDL during exacerbation was profoundly reduced: 1.02 (0.33) (P = 0.022). HDL from patients with active CD and CD patients in remission was characterized by a reduced ability to attenuate oxidation compared with controls (P = 0.008 and P = 0.024 respectively). Patients with CD have increased IMT compared with matched controls, indicative of accelerated atherogenesis. The changes during CD exacerbation in terms of HDL concentration and composition imply a role for impaired HDL protection in these patients.